Interview | Dr. Jordi Casanellas, Director of AI at Bayer Pharma | Artificial Intelligence in Berlin

Artificial intelligence is transforming healthcare – from how new drugs are discovered to how clinical trials are conducted and diagnoses are made. At Bayer, these advances are directly tied to the company’s mission of “Health for all, hunger for none” – with AI accelerating target identification, optimizing compound screening and improving patient safety through more efficient and transparent processes. 

Dr. Jordi Casanellas, Director of AI at Bayer Pharma in Berlin, is helping to drive these developments at the intersection of science, technology and ethics. In this interview, he explains how AI is revolutionizing drug discovery and clinical trials, the safeguards Bayer has put in place to ensure transparency and compliance – and why Berlin has become a strategic hub for Bayer’s global AI efforts. He also highlights collaborations with local partners such as AIgnostics and Charité, and looks ahead to the next big leap: embedding AI across the healthcare value chain to bring better therapies to patients faster.

The interview was conducted by #ai_berlin. Link to the interview.